NCT00462956View on ClinicalTrials.gov

GW572016 In Patients With Advanced Or Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 20, 2006

Study Completion Date

December 20, 2006

Conditions
Neoplasms, Breast
Interventions
DRUG

Tykerb

lapatinib 1500mg daily

Trial Locations (9)

791-0280

GSK Investigational Site, Ehime

802-0077

GSK Investigational Site, Fukuoka

241-0815

GSK Investigational Site, Kanagawa

350-1298

GSK Investigational Site, Saitama

320-0834

GSK Investigational Site, Tochigi

104-0045

GSK Investigational Site, Tokyo

113-8677

GSK Investigational Site, Tokyo

135-8550

GSK Investigational Site, Tokyo

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY